Eczema trials recruiting in Wisconsin

All Eczema trials nationally

Cities in Wisconsin

Recruiting trials in Wisconsin

• A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
  NCT06461897 · Phase: Phase 3 · Ages: 2 Years to 11 Years · Sex: All (male and female) · Wisconsin: Milwaukee
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor
  NCT06241118 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Wisconsin: Milwaukee
• Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
  NCT06504160 · Phase: Phase 1 · Ages: 6 Years and older · Sex: All (male and female) · Wisconsin: Madison